Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Clinical trial NCT02431429 · COMPLETED

Trial details

NCT number: NCT02431429
Sponsor: Knight Therapeutics (USA) Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Mucocutaneous Leishmaniasis

Start date: 2015-07-01
Primary completion: 2018-02-23
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.